- Oral Antiplatelet Therapy in Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction, ST-Segment Elevation Myocardial Infarction, and Percutaneous Coronary Intervention: Is it Time for a Guideline Update?
[作者:Saucedo, JF,期刊:American Journal of Cardiology, 页码:4C-8C , 文章类型: Article,,卷期:2009年104-5A]
- Oral antiplatelet drugs are central in the management of acute coronary syndromes, including unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous co...
- Definition, Incidence, Correlates, and Clinical Impact of "Nuisance" Bleeding in Patients Undergoing Drug-Eluting Stent Implantation
[作者:Waksman, R,期刊:American Journal of Cardiology, 页码:30C-33C , 文章类型: Article,,卷期:2009年104-5A]
- Nuisance bleeding, or superficial bleeding, after antiplatelet therapy is not well characterized despite its potential to affect patient compliance and premature cessation of oral antiplatelet therapy, which can lead to ...
- Anemia, Hemorrhage, and Transfusion in Percutaneous Coronary Intervention, Acute Coronary Syndromes, and ST-Segment Elevation Myocardial Infarction
[作者:Willis, P; Voeltz, MD,期刊:American Journal of Cardiology, 页码:34C-38C , 文章类型: Article,,卷期:2009年104-5A]
- Advances in antithrombotic and antiplatelet therapies have led to a reduction in ischemic event rates in percutaneous coronary intervention (PCI), acute coronary syndromes (ACS), and ST-segment elevation myocardial infar...
|